BIO 2021 Notebook: A Breakthrough Year For Emerging Companies?

 
• By Pink Sheet Team and Scrip Team
BIO 2021 Notebook - Day 2
BIO included updates on the Reagan-Udall RWE accelerator project and the need to put digital product data into context for stakeholders.

More from US FDA Performance Tracker

More from Regulatory Trackers